Stammers Alfred H, Trowbridge Cody C, Marko Molly, Woods Edward L, Brindisi Nicholas, Pezzuto James, Klayman Myra, Fleming Sean, Petzold Joseph
Department of Perfusion Services, Geisinger Health Systems, Danville and Wilkes Barre, Pennsylvania, USA.
J Extra Corpor Technol. 2009 Dec;41(4):P25-30.
Autologous platelet-gel (APG) is the process of harvesting ones own cells (platelets), concentrating them most often through centrifugation, exposing them to an agonist which induces activation which releases intrinsic substances, and applying them to a target area to accelerate wound healing. APG is attractive because it concentrates a large number of biologically active substances, which are primarily proteins that participate in complex series of mechanisms involved in inflammation and wound healing. It has been used in numerous applications including sports medicine, dermatology, and surgery. However, there are few prospective randomized trials that have compared it in a rigorous manner to other techniques or to placebo. The following report is a review of APG, which includes a description of its perceived benefit, identification of the various modalities where it has been used, and criticisms concerning its use.
自体血小板凝胶(APG)是一个采集自身细胞(血小板)的过程,通常通过离心对其进行浓缩,将其暴露于能诱导激活从而释放内在物质的激动剂中,然后将其应用于目标区域以加速伤口愈合。APG具有吸引力,因为它能浓缩大量生物活性物质,这些物质主要是参与炎症和伤口愈合复杂机制系列的蛋白质。它已被用于众多领域,包括运动医学、皮肤病学和外科手术。然而,很少有前瞻性随机试验以严格的方式将其与其他技术或安慰剂进行比较。以下报告是对APG的综述,包括对其预期益处的描述、已使用它的各种方式的识别以及对其使用的批评。